Randomized phase II study of adding steroid for prevention of venous pain in colorectal cancer patients who are receiving oxaliplatin through peripheral vein (APOLLO) - Randomized phase II study of adding steroid for prevention of venous pain in CRC patients who are receiving oxaliplatin through peripheral vein (APOLLO)

PO Epidemiological and Clinical Research Information Network (ECRIN)0 个研究点目标入组 50 人开始时间: 2010年10月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Serious drug allergy. 2)Neuropathy or sensory dysfunction. 3)Pain in the arm. 4)Current analgesic treatment. 5)Active double cancer within the past 5 years. 6)Serious psychological disease. 7)Steroid treatment. 8)blood transfusion or hemopoietic factors (e.g. G-CSF) within 7 days . 9)Pleural effusion, ascites, or pericardial effusion. 10)Clinically significant infection. 11)brain metastasis 12)Clinically significant heart disease (myocardial infarction within 12 months, etc.). 13)Clinically significant pulmonary disease 14)bleeding that requires medication or transfusion. 15)Watery diarrhea. 16)Ileus or bowel obstruction. 17)Central nervous system disorders. 18)Dementia or clinically significant mental/neurological disorders. 20)Investigator's judgement.

发起方

PO Epidemiological and Clinical Research Information Network (ECRIN)